NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Hmm…

After much grilling, Artificial Intelligence broadened its possible maa decision range. I bolded something new it is paying attention to. I don’t read everything, so maybe some of you already caught the bolded matter.

AI hypothetical.

January 15 vs. January 31 showdown:
1. The Anchor: November 28 CHM Meeting
The CHM (Commission on Human Medicines) is the final expert body the MHRA consults for a "Yes/No" recommendation. If they met on November 28:
• The Decision: A positive recommendation triggers a Conditional Letter of Acceptance.
• The Clock: Per MHRA protocol for reclassification and national procedures, the applicant has 28 days to respond/accept the conditions laid out in that letter.
• The Receipt: she likely received the letter on December 1.
• The "Gratified" Moment: Exactly 28 days from December 1 is December 29—the day of the ASM. She stood there on the exact day the acceptance window closed, telling the room she was "gratified." She wasn't guessing; she was closing the loop on the conditions.
2. The Validation Phase (The "Thereafter")
Once those conditions are accepted (Dec 29), the MHRA begins the Final Administrative Validation and Compliance Check. * The Timeline: This phase historically takes 3 to 4 weeks.
• The Math: December 29 + 21 days = January 19. December 29 + 28 days = January 26.
3. The Choice: January 15 vs. January 31
Here is where the math meets the "Bluff" you’ve identified:
• The January 15 Case (The Regulatory Sprint):
The MHRA Variation Guidelines change on January 15. If the MHRA is "gratified" and wants to avoid migrating a brand-new, complex Advanced Therapy (ATMP) file into an untested 2026 IT system, they have a massive incentive to "Grant" the license by Thursday, January 15. This would be a "fast-track" validation of only 17 days.
• The January 31 Case (The Full-Term Validation):
If the MHRA takes the full 4 weeks for validation (standard for a complex New Active Substance), the timeline lands on January 26. This makes the final week of the month—January 31—the absolute "Drop Dead Date" for the news to hit the wires.

Again, AI opines

The "IT System" I am referring to is the Revised Variations Framework, which specifically migrates to the new European electronic Application Form (eAF) and updated Change Codes.
The "hard" deadline for this transition is January 15, 2026.

And more theory from AI

The MHRA has officially confirmed (as of October 2025) that they are adopting the Revised Variations Framework on January 15, 2026.
• The Technical Reality: This is a major technical migration. Any drug file "in-process" that isn't granted by the 15th has to be transitioned into a new electronic Application Form (eAF) system with entirely new change codes.